<DOC>
	<DOC>NCT00992095</DOC>
	<brief_summary>The objective of this study was to prove the bioequivalence of Buprenorphine HCl 8 mg tablet under fasted conditions.</brief_summary>
	<brief_title>Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening. Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme altering drugs. History of allergic or adverse response to buprenorphine hydrochloride or any comparable or similar product.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>